Bioforce Medicines Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 12-07-2024
- Paid Up Capital ₹ 0.10 M
as on 12-07-2024
- Company Age 34 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.20 M
as on 12-07-2024
- Revenue %
(FY 2021)
- Ebitda
- Net Worth
- Total Assets %
(FY 2021)
About Bioforce Medicines
The Corporate was formerly known as Shree Siddhivinayaka Medical & Surgical Aids Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.20 M.
Nalini Batra and Pranav Batra serve as directors at the Company.
- CIN/LLPIN
U99999MH1990PTC058212
- Company No.
058212
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 1990
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bioforce Medicines?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nalini Batra  | Managing Director | 07-May-2005 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pranav Batra | Additional Director | 12-Feb-2021 | Current |
Financial Performance and Corporate Structure Insights of Bioforce Medicines.
Bioforce Medicines Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bioforce Medicines?
In 2021, Bioforce Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Henbane Pharma (India) Private LimitedActive 22 years 6 monthsNalini Batra and Pranav Batra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Rassion Catholic Co-Op Bank Ltd Creation Date: 09 Dec 1990 | ₹0.20 M | Open |
How Many Employees Work at Bioforce Medicines?
Unlock and access historical data on people associated with Bioforce Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bioforce Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioforce Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
